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Long-distance travel across multiple time zones presents unique challenges for patients taking insulin, requiring
adjustments in both timing and dosage of basal insulin when several times zones (≥5) are traversed. Travel across
the International Date Line adds to the confusion, as existing resources and dosing calculators often do not
account for the date change. We review recommendations from available guidelines and dosage calculators used
for long-distance travel basal insulin adjustments and then present our patient handouts which allow for a safe,
specific, single dose adjustment for eastward and westward travel. The included handouts are easy to use and can
be freely reproduced for use in diabetes clinics.
Keywords: Diabetes, Hypoglycemia, Insulin, TravelBackground
Patients with diabetes who take insulin face many
unique challenges related to travel to include dehydra-
tion and hypoglycemia. Dehydration, a well documented
risk associated with long-distance air travel, is accen-
tuated in patients with diabetes; and extreme dehy-
dration without proper insulin adjustment has been
reported to trigger DKA [1]. Air travel also increases the
risk of hypoglycemia, requiring adjustment of the dosage
and timing of insulin administration [2].
Only a handful of resources offer travel guidance to
patients who take insulin. These include publications
targeting physicians, generalized information for patients
and online dosage calculators. While they are all well
written and offer good advice, many limit their scope to
storage and transportation of supplies, immunizations
and diet advice making them too generalized to answer
specific insulin dosing questions [3-6]. Older publi-
cations generally review adjusting intermediate acting
insulin (Lente, NPH), often used in combination with
regular insulin, and are therefore less helpful for patients
taking multiple daily injection (basal-bolus) regimens
[7,8]. Other guidelines, while extremely detailed and well
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reproduction in any medium, provided the orfigures which can potentially be overwhelming for pa-
tients and providers looking for a simple guide to adjus-
ting insulin [9,10]. Few publications explicitly address
the issue of crossing the International Date Line (IDL)
with sufficient detail to create a patient-friendly insulin
adjustment plan.
Electronic dosage calculators, while helpful, require
the patient to enter a significant amount of information
online [11]. We are not aware of any online calculator
that consistently accounts for crossing the IDL.
Our diabetes clinic, in a tertiary care medical center lo-
cated in Honolulu, Hawaii is only 2 time zones away from
the IDL and provides care to children and adult patients
from across the western Pacific. Given our remote loca-
tion, patients presenting for care frequently travel across
multiple time zones east or west and routinely ask how to
adjust their insulin when traveling back and forth across
the IDL. In response to this need, we have developed
detailed yet user-friendly patient handouts allowing phy-
sicians to offer patient-specific basal insulin dosing adjust-
ment recommendations for long distance travel using only
a single dose change [see Additional file 1].
In this review we discuss general rules for adjusting in-
sulin during travel for patients on multiple daily injec-
tion (basal-bolus) regimens. We also include our patient
handouts for eastward and westward travel that incor-
porate a single insulin dose adjustment for basal insulin,
and review examples for multiple travel scenarios. AsLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vide advice for adjusting insulin for travel, and little scien-
tific evidence to support their recommendations, we must
emphasize that the advice given in this review is expert
opinion based on our extensive clinical experience and
knowledge of insulin pharmacokinetics, and is not evi-
dence based.
General rules for travel while taking insulin
Avoidance of hypoglycemia is the well-accepted primary
goal during air travel. Hypoglycemia reportedly occurs
in up to 10% of patients taking insulin while traveling
abroad, either during travel or in the first 24 hours after
arrival [12]. Many factors contribute to this increased
risk, including changes in dietary patterns and difficul-
ties in adjusting insulin dose and timing appropriately
[2]. To reduce this risk of hypoglycemia recommenda-
tions have included removal and replacement of syringe
plungers to allow pressure equalization prior to use for
in-flight injections, and reduction in the amount of air
normally injected into the insulin vials [13]. Changes in
air pressure also affect insulin pumps with a reduction
in air pressure occurring during ascent potentially resul-
ting in unintended insulin delivery, yet no specific prac-
tice guideline currently recommends changes to insulin
pump settings for travel [14].
Adjustments to insulin dosage
Although many physicians appear reluctant to offer de-
tailed advice on adjusting insulin doses for travel [15], the
goal is actually quite straightforward; design an insulin
regimen that is very simple and avoids hypoglycemia, even
if this leads to a short period of suboptimal glycemic con-
trol (hyperglycemia). In general it is best to avoid compli-
cated advice, such as to give frequent rapid acting insulin
doses until it is time for basal insulin at the new location.
In our experience complicated plans generally confuse
patients and are therefore not well followed. Instead,
adjusting basal insulin with a single dose change is the
simplest method.
Short duration trips are typically easy. When traveling
across fewer than 5 time zones or for trips less than 3 days
duration, we recommend patients keep their watches set
at their home local time, continue their basal insulin at
the usual times and administer bolus doses before meals.
Similarly, patients on insulin pumps taking only rapid ac-
ting insulin continue with their usual regimen regardless
of duration of travel, simply adjusting the time on their
insulin pump to local time on arrival so their basal rates
adjust accordingly.
Traveling across 5 or more time zones and staying in a
different time zone longer than 3 days disrupts meal
times and medication dosages/times such that patients
need a detailed plan to ensure a seamless transition[10,16]. As noted above, similar to short duration travel,
patients on insulin pumps taking only rapid acting insu-
lin continue with their usual regimen, adjusting the time
on their insulin pump to local time on arrival so their
basal rates adjust accordingly. Rapid acting bolus doses
via insulin pump or subcutaneous injection are still
given before meals. However for patients taking long
acting basal insulin, travel requires a 4% adjustment to
the insulin dose for each time zone traversed (1 hour is
4% of the 24 hour day); with westward travel resulting in
missed doses and eastward travel resulting in excess
doses. Traveling across 5 time zones or more thereby
necessitates a dose adjustment to prevent a clinically sig-
nificant change in blood glucose.
In the following section, we offer 4 examples of long
distance travel scenarios for patients on once or twice
daily basal insulin regimens, demonstrate how to fill out
our patient handouts and provide detailed yet easily
understood patient instructions for basal insulin dosage
adjustment.
Example 1. Westward travel from New York to Honolulu
Scenario #1 – once daily basal insulin adjustment
Patient A with type 1 diabetes (T1D) is traveling west
from New York to Honolulu. He currently takes glargine
20 units at 8 PM every night and rapid acting insulin be-
fore meals as part of his basal-bolus regimen. The flight
departs at 10 AM Eastern Standard Time (EST). Total
travel time is 11 hours.
Using the Westward Travel Handout (Figure 1), infor-
mation on the starting time at departure is recorded
along with the last time basal insulin was given; in this
case glargine 20 units at 8 PM the prior evening. The
notes in the middle of the handout are there to remind
patients to 1) continue to use rapid acting insulin during
their flight as they would normally do, adjusting for the
amount of food eaten; and 2) remind them that if their
basal insulin is due during flight, they should only take
half of it (half the normal dose).
His watch should still be on departure time (EST)
when due his next basal insulin dose, he takes half the
normal dose (10 units glargine) at 8 PM EST. AFTER
the basal insulin is given, he changes his watch to the
destination time. Upon landing in Honolulu, the day is
now ‘longer’ despite 11 hours having passed as it is only
3 PM Hawaii-Aleutian Standard Time (HST). As only
half the basal insulin was given earlier in the day, he can
then give the other half (10 units glargine) at 8 PM HST,
whether this is on the plane or after the plane has
landed. In this case the second half of the dose is given
after landing in Hawaii. The next night, he resumes his
normal insulin dosing at the new location.
By giving half the dose at 2 different times, the glargine
dose is extended out to cover the longer day. Although
Figure 1 Calculation for insulin dose change. This example
shows the basal insulin dose change for example 1, scenario 1,
New York to Honolulu.
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either end of the dosing schedule, the primary goal of pre-
venting hypoglycemia is achieved while still giving insulin
in a simple manner.
Patients may ask an important question, “How do I
know what the destination time is to switch my watch to?”
We recommend using a smartphone to do this by adding
the destination city to the standard worldclock app. The
handout also includes a space to write this out in advance
for the patient. Alternately most flight attendants would
be happy to assist, but we recommend the entire form be
completed before the patient starts his travels. Use of a
time zone map (www.worldtimezone.com/wtz-pacific24.
php) can help to determine how many time zones are
traversed.
Scenario #2 – twice daily basal insulin adjustment
Patient B is traveling west from New York to Honolulu.
Instead of once daily glargine, the patient takes detemir 10
units twice daily at 8 AM and 8 PM, and rapid acting
insulin before meals as part of the basal-bolus regimen.
Although the patient takes twice daily basal insulin, the
same handout used in the previous example works well
and can be used again. The same flight departs at 10 AM
EST. Total travel time is 11 hours.This scenario is very similar to the previous example as
the patient takes the total dose of basal insulin the morning
before departure. Because detemir does not last quite as
long as glargine, a dose becomes due during the flight; half
the total dose (5 units detemir) should be given at that time
(8 PM EST). Upon arrival at Honolulu, the patient adjusts
his watch to HST and the other half of the basal dose (5
units detemir) is given at 8 PM HST. The normal dosing
regimen resumes starting at 8 AM again.
Example 2. Westward travel from Los Angeles to Seoul,
South Korea (across the IDL)
Scenario #1 – once daily basal insulin adjustment
The same formula works well when traveling across the
IDL. Patient A is traveling west from Los Angeles to
Seoul, South Korea. He currently takes glargine 20 units
at 8 PM every night and rapid acting insulin before meals
as part of his basal-bolus regimen. The flight departs at
11:00 AM Pacific Standard Time (PST) on February 1st
from Los Angeles and because the flight crosses the IDL,
it arrives the next day (February 2nd) at 9:00 PM Korean
Standard Time (KST) in South Korea. Although the trip is
very long (almost 18 hours), crosses the IDL, and has a
3-hour layover in Tokyo, using our handout overcomes
these complexities. We can use our formula to devise a
simple basal insulin dose adjustment.
Using the Westward Travel Handout (Figure 2), infor-
mation on the starting time at departure is written down
as well as the last time basal insulin was given. In this
case, glargine 20 units at 8 PM the prior evening. The
patient’s watch should still be on departure time (PST)
when 9 hours through the trip, his basal insulin becomes
due. He gives half the normal dose (10 units glargine),
then AFTER giving the basal insulin, he changes his
watch to KST. In 8 more hours, it will be 8 PM KST. He
still will not have arrived at the destination, but it does
not matter. Because only half the basal insulin was given
earlier in the day, he can then give the other half at
8 PM KST. He then resumes his normal insulin on at
the new location, giving a full 20 units of glargine at
8 PM the next night on KST.
Example 3. Eastward travel from Honolulu to New York
Scenario #1 – once daily basal insulin adjustment
Now let’s plan eastward travel for the same patient. When
traveling east, it is important to recognize that the day gets
shorter, so the basal insulin dose given during travel must
be adjusted one time using the formula:
TravelDose ¼ NormalDose 0:9− #of TimeZonesCrossed
HoursBetweenBasal InsulinDoses
 
This formula is adapted and modified from a previous
reference [9]. The formula calculates the amount of in-
sulin needed to bridge the gap between the departure
Figure 3 Calculation for insulin dose change. This example
shows the basal insulin dose change for example 3, scenario 1,
Honolulu to New York.
Figure 2 Calculation for insulin dose change. This example
shows the basal insulin dose change for example 2, scenario 1,
Los Angeles to Seoul, South Korea.
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accounting for the shorter day. The formula automa-
tically reduces the amount of insulin given by 10-20%,
depending on the length of travel, with a larger dose re-
duction calculated for longer flights, as longer flights are
more likely to adversely affect diurnal rhythm and eating
patterns, potentially increasing the risk of hypoglycemia.
To see how it works, let us consider Patient A with T1D
traveling home from Honolulu to New York. He cur-
rently takes glargine 20 units at 8 PM every night and
rapid acting insulin before meals as part of his basal-
bolus regimen. The flight departs at 3 PM HST and ar-
rives 7 AM EST. Total flight time is 10 hours.
Using the Eastward Travel Handout (Figure 3), we see
that only a single dosage reduction is needed. After the
reduced travel dose is given, the patient resumes their
normal dosing. A detailed explanation of what informa-
tion to put into the formula is discussed in Figure 4.
Information on the local time at departure is written
down on the handout as well as the last time basal insu-
lin was given before departure, glargine 20 units at 8 PM
the prior evening. At 8 PM HST only 13 units of glar-
gine are given per the formula on the handout. AFTER
the basal insulin is given, the patient changes his watch
to EST. The next full dose of glargine is due 8 PM EST
after they arrive, which turns out to be 18 hours afterthe last dose. This reduced time between doses is why
the patient took just under ¾ of his usual glargine dose
on the flight.
Scenario #2 – twice daily basal insulin adjustment
Patient B is traveling home from Honolulu to New York.
He currently takes detemir 10 units twice daily, at 8 AM
and 8 PM and rapid acting insulin before meals as part
of his basal-bolus regimen. The flight departs at 3:00 PM
HST and arrives 7 AM EST. Total flight time is 10 hours.
Although the patient takes twice daily basal insulin, the
same handout used in the previous example works well
and can be used again.
Using the Eastward Travel Handout, information on
the local time at departure is written down as well as the
last time basal insulin was given before departure, dete-
mir 10 units at 8 AM that morning. The first dose of
basal insulin due while traveling is at 8 PM Honolulu
time. Per the formula on the handout only 4 units of
detemir are given. AFTER the basal insulin is given, he
changes his watch to EST. The next full dose of detemir
is due 8 AM EST after he arrives, which turns out to be
6 hours after the last dose. This reduced time between
doses is why the patient took just under ½ of his usual
detemir dose on the flight, a dose that normally lasts
12 hours.
To calculate the new dose to use on the handout, use the formula and enter:
1) The normal basal insulin dose.
2) The number of time zones crossed. Note this may be different than the time difference 
between the locations if crossing the IDL. For example, Seoul, South Korea is 8 time zones away 
from Los Angeles, even though they have a 16 hour time difference. Use of a time zone map 
(www.worldtimezone.com/wtz-pacific24.php) can help to determine how many time zones are 
traversed.
3) Hours between basal insulin doses. Enter 24 if giving insulin once daily. For twice daily basal 
insulin, it would be 12 hours.
4) As noted in the Important Considerations section, the travel dose offered by the formula is a 
recommendation, and providers may want to adjust the dose for each individual patient.
* Adapted and modified from the Saskatchewan Advanced Insulin Dose Adjustment Module [9].  
Figure 4 Formula for eastward travel. When traveling east, the day gets shorter. A reduced basal insulin dose is given once to account for the
fact that the next dose will be due sooner than usual. The formula automatically reduces the amount of insulin given by 10-20%, depending on
the length of travel, with a larger dose reduction calculated for longer flights, as longer flights are more likely to adversely affect diurnal rhythm
and eating patterns, potentially increasing the risk of hypoglycemia.
Figure 5 Calculation for insulin dose change. This example
shows the basal insulin dose change for example 4, scenario 1,
Seoul, South Korea to Los Angeles.
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Los Angeles (across the IDL)
Scenario #1 – once daily basal insulin adjustment
Patient A is traveling from Seoul, South Korea to Los
Angeles. He currently takes glargine 20 units at 8 PM
every night and rapid acting insulin before meals as part
of his basal-bolus regimen. The flight departs 9 AM on
February 1st from Seoul and has a 3 hour layover in
China. Because the flight crosses the IDL, it arrives the
same day at 10 AM in Los Angeles, even though the
total travel time is 17 hours. This sounds very confusing,
but if you fill out the handout for the patient it turns out
to be quite simple.
Using the Eastward Travel Handout (Figure 5), infor-
mation on the local time at departure is written down
(9 AM KST) as well as the last time basal insulin was
given before departure, glargine 20 Units at 8 PM the
night before departure. At 8 PM KST only 11 units of
glargine are given per the formula on the handout.
AFTER the reduced basal insulin dose is given, he
changes his watch to Los Angeles time (PST). The next
dose of glargine is due at 8 PM PST after he arrives,
which turns out to be 16 hours after the last dose. This
reduced time between doses is why the patient only took
just under ⅔ of their usual glargine dose on the flight.
Note that you can disregard the date, and the formula
still works!
Important considerations
Prevention of hypoglycemia while providing adequate in-
sulin coverage is the challenge of diabetes management
while traveling, and the use of a split basal insulin dose
when traveling west or a reduced basal insulin dose
when traveling east offers a safe, simple solution. While
there are several published regimens for adjusting insu-
lin for long-distance travel, our method using a single
dose change is safe and simple. If following the handout,patients do not even need to know their destination time
zone conversion. They simply adjust their watch once
per the instructions on the handout.
Despite the simplicity of these instructions, individual
patient care and provider preference remain important
considerations. For example, even with the 10-20% dose
reduction built in to the eastward travel formula (Figure 4),
some providers may not feel comfortable giving a reduced
dose of glargine for eastward travel, and may want to
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travel to mitigate the risk of hypoglycemia. Also, if the
eastward travel formula shows a requirement for only a
small insulin dose to cover just a few hours of time before
the next scheduled full dose of basal insulin, many
diabetes care providers would recommend skipping that
dose, again to mitigate the risk of hypoglycemia. Daylight
savings time, observed in the continental United States
and some other countries, is yet another consideration,
changing the calculated number of time zones between
locations by 1 hour depending on the time of year. This
small change however is of limited clinical relevance.
Conclusion
Patients need easy to understand, straightforward instruc-
tions for adjusting basal-bolus insulin regimens during
travel. Our handouts [see Additional file 1] address most
scenarios in a straightforward manner, providing a safe
and simple dosing regimen for most extended travel
situations.
Our future goal is to move these handouts into an on-
line dosage calculator or smartphone app. For now, we
encourage physicians and diabetes providers to use our
freely available, simplified handouts to help patients
prevent hypoglycemia while safely enjoying their travels.Additional file
Additional file 1: Travel handouts. Detailed yet simple patient
handouts allowing for patient-specific basal insulin dosing adjustment
recommendations for long distance travel using only a single dose
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